{"id":"cellular-and-tissue-based-products","safety":{"commonSideEffects":[{"rate":"null","effect":"Infection"},{"rate":"null","effect":"Allergic reaction"}]},"_chembl":{"chemblId":"CHEMBL324631","moleculeType":"Small molecule","molecularWeight":"643.29"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by promoting the growth and proliferation of cells and tissues, which helps to repair damaged or diseased areas. This can be particularly useful for treating wounds and other tissue damage.","oneSentence":"This drug stimulates cellular and tissue repair.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:50:31.041Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of chronic wounds"}]},"trialDetails":[{"nctId":"NCT07498218","phase":"PHASE1","title":"Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue","status":"NOT_YET_RECRUITING","sponsor":"Ayu, Inc.","startDate":"2026-03-02","conditions":"Diabetic Foot Ulcer (DFU), Granulation of Chronic Diabetic Wounds","enrollment":24},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT04965597","phase":"PHASE2","title":"Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2022-04-19","conditions":"Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia","enrollment":40},{"nctId":"NCT00716066","phase":"PHASE2","title":"Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2008-06","conditions":"Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune","enrollment":53},{"nctId":"NCT01625351","phase":"PHASE1","title":"A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2012-08-20","conditions":"Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor","enrollment":23},{"nctId":"NCT05757310","phase":"PHASE1","title":"A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-11-15","conditions":"Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia","enrollment":6},{"nctId":"NCT05457556","phase":"PHASE3","title":"Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2023-03-15","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia","enrollment":435},{"nctId":"NCT04083183","phase":"PHASE1, PHASE2","title":"Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2020-06-16","conditions":"Non-Malignant Neoplasm","enrollment":40},{"nctId":"NCT03622788","phase":"PHASE1, PHASE2","title":"Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2019-08-08","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia","enrollment":16},{"nctId":"NCT07236151","phase":"PHASE2","title":"Sequential CD19/CD22 CAR-T Cell Therapy Following ASCT","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2020-02-24","conditions":"Large B-cell Lymphoma, CAR T Cell Therapy, Auto Stem Cell Transplant","enrollment":23},{"nctId":"NCT01857934","phase":"PHASE2","title":"Therapy for Children With Advanced Stage Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2013-07-05","conditions":"Neuroblastoma","enrollment":153},{"nctId":"NCT02727803","phase":"PHASE2","title":"Personalized NK Cell Therapy in CBT","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-05-19","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia","enrollment":100},{"nctId":"NCT07137130","phase":"NA","title":"Secretome TGF Beta 3","status":"NOT_YET_RECRUITING","sponsor":"Indonesia University","startDate":"2026-02-14","conditions":"Melasma","enrollment":34},{"nctId":"NCT04530487","phase":"PHASE2","title":"Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-08-19","conditions":"Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small Round Cell Tumor","enrollment":1},{"nctId":"NCT02162420","phase":"NA","title":"Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2015-01-10","conditions":"Dyskeratosis Congenita, Aplastic Anemia","enrollment":61},{"nctId":"NCT02673905","phase":"NA","title":"Clinical Trial for the Regeneration of Cartilage Lesions in the Knee","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2016-11","conditions":"Tear; Knee, Cartilage, Articular","enrollment":108},{"nctId":"NCT01701986","phase":"PHASE1, PHASE2","title":"Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-10-25","conditions":"Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma","enrollment":64},{"nctId":"NCT06841861","phase":"PHASE1, PHASE2","title":"Spermatogonial Differentiation Via Testicular Organoid","status":"RECRUITING","sponsor":"CellARTs Inc.","startDate":"2024-03-28","conditions":"Infertility, Male, Gene Abnormality, Sterility, Male","enrollment":100},{"nctId":"NCT01413100","phase":"PHASE2","title":"Scleroderma Treatment With Autologous Transplant (STAT) Study","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2011-09-15","conditions":"Systemic Scleroderma","enrollment":21},{"nctId":"NCT06674980","phase":"NA","title":"Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs","status":"RECRUITING","sponsor":"C5 Biomedical","startDate":"2024-12-20","conditions":"Pathologic Processes, Diabetes Mellitus, Glucose Metabolism Disorders","enrollment":177},{"nctId":"NCT06441955","phase":"PHASE4","title":"Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.","status":"RECRUITING","sponsor":"Well- Konnect Healthcare Services and Research Firm","startDate":"2024-03-01","conditions":"COVID-19, Long Haul","enrollment":100},{"nctId":"NCT04521946","phase":"PHASE1","title":"Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-01-14","conditions":"Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, Central Nervous System Germ Cell Tumor","enrollment":""},{"nctId":"NCT04776850","phase":"EARLY_PHASE1","title":"Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-12-29","conditions":"Beta Thalassemia Major, Sickle Beta 0 Thalassemia, Sickle Beta Plus Thalassemia","enrollment":""},{"nctId":"NCT06516419","phase":"NA","title":"Development of Products Based on Secretom From Stem Cell Conditioned Medium for Melasma Therapy","status":"RECRUITING","sponsor":"Dr.dr.Irma Bernadette, SpKK (K)","startDate":"2024-02-13","conditions":"Melasma","enrollment":90},{"nctId":"NCT01664910","phase":"PHASE1, PHASE2","title":"CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-10-29","conditions":"Hematopoietic and Lymphoid Cell Neoplasm","enrollment":27},{"nctId":"NCT06492811","phase":"PHASE2","title":"Efficacy and Safety of a Hydrogel Containing Cascade Catalytic Enzymes in the Treatment of Diabetic Wounds","status":"ACTIVE_NOT_RECRUITING","sponsor":"The First Affiliated Hospital of University of South China","startDate":"2024-04-01","conditions":"Diabetic Wound","enrollment":49},{"nctId":"NCT01033552","phase":"PHASE1, PHASE2","title":"Biochemical Correction of Severe EB by Allo HSCT and \"Off-the-shelf\" MSCs","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2010-01","conditions":"Epidermolysis Bullosa","enrollment":32},{"nctId":"NCT02700841","phase":"PHASE2","title":"Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation","status":"TERMINATED","sponsor":"University of Nebraska","startDate":"2020-01-09","conditions":"Plasma Cell Myeloma","enrollment":8},{"nctId":"NCT02872831","phase":"NA","title":"Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle","status":"TERMINATED","sponsor":"Thomas Jefferson University","startDate":"2016-07","conditions":"Pancreatic Cancer, Lymphadenopathy, Cholangiocarcinoma","enrollment":376},{"nctId":"NCT06269523","phase":"NA","title":"Effects of Rehabilitation and Kinesio Taping to Prevent Axillary Web Syndrome After Breast Cancer Surgery","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2021-07-21","conditions":"Axillary Web Syndrome","enrollment":18},{"nctId":"NCT02464878","phase":"PHASE2","title":"Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-01","conditions":"Kidney Transplant, Type 1 Diabetes","enrollment":2},{"nctId":"NCT00611351","phase":"PHASE2","title":"Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2005-06-07","conditions":"Graft Versus Host Disease, Leukemia, Lymphoma","enrollment":5},{"nctId":"NCT02757885","phase":"PHASE2","title":"Transplantation for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-07-10","conditions":"Sickle Cell Disease","enrollment":10},{"nctId":"NCT03096782","phase":"PHASE2","title":"Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-10-13","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia","enrollment":6},{"nctId":"NCT03930459","phase":"NA","title":"Efficacy of Ex-situ Normothermic Perfusion Versus Cold Storage in the Transplant With Steatotic Liver Graft.","status":"TERMINATED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2019-04-26","conditions":"Liver Transplant","enrollment":7},{"nctId":"NCT02661035","phase":"PHASE2","title":"Allo HSCT Using RIC for Hematological Diseases","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2017-03-09","conditions":"Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia","enrollment":156},{"nctId":"NCT02122081","phase":"PHASE1","title":"Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies","status":"COMPLETED","sponsor":"Sumithira Vasu","startDate":"2015-07-27","conditions":"Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities","enrollment":33},{"nctId":"NCT00074269","phase":"PHASE2","title":"Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer","status":"TERMINATED","sponsor":"University of California, San Diego","startDate":"2003-07","conditions":"Breast Cancer","enrollment":5},{"nctId":"NCT00253435","phase":"PHASE2","title":"N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma","status":"COMPLETED","sponsor":"Children's Hospital Los Angeles","startDate":"2005-09","conditions":"Neuroblastoma","enrollment":50},{"nctId":"NCT05322330","phase":"PHASE2","title":"Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2022-02-10","conditions":"Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma","enrollment":20},{"nctId":"NCT03004976","phase":"PHASE2","title":"Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke","status":"COMPLETED","sponsor":"Joanne Kurtzberg, MD","startDate":"2017-03-14","conditions":"Stroke, Stroke, Acute, Brain Injury, Acute","enrollment":79},{"nctId":"NCT01811368","phase":"PHASE2","title":"Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma","status":"UNKNOWN","sponsor":"Joseph Tuscano","startDate":"2013-03-12","conditions":"Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma","enrollment":20},{"nctId":"NCT01168219","phase":"PHASE2","title":"Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2010-07-15","conditions":"Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia","enrollment":68},{"nctId":"NCT00579527","phase":"PHASE1, PHASE2","title":"Phase I/II Thymus Transplantation With Immunosuppression #950","status":"COMPLETED","sponsor":"Sumitomo Pharma Switzerland GmbH","startDate":"2005-12-19","conditions":"DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly","enrollment":14},{"nctId":"NCT05234086","phase":"PHASE2","title":"Cell Therapy for Diabetic Foot Ulcer","status":"UNKNOWN","sponsor":"Instituto para el Desarrollo Biotecnológico y la Innovación S.A.","startDate":"2020-01-02","conditions":"Diabetic Foot Ulcer Associated With Type II Diabetes Mellitus, Wound Heal","enrollment":60},{"nctId":"NCT05214872","phase":"","title":"The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease","status":"COMPLETED","sponsor":"Poznan University of Medical Sciences","startDate":"2016-03-25","conditions":"Atherosclerosis of Artery, Inflammation, Chronic Kidney Diseases","enrollment":252},{"nctId":"NCT02083250","phase":"PHASE1","title":"Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-03-06","conditions":"Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell Transplantation Recipient","enrollment":70},{"nctId":"NCT01471444","phase":"PHASE3","title":"Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-11-02","conditions":"Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection","enrollment":256},{"nctId":"NCT00258427","phase":"PHASE2","title":"Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2002-03-26","conditions":"Fanconi Anemia","enrollment":14},{"nctId":"NCT05024656","phase":"NA","title":"AmnioExcel® Plus vs SOC in the Management of Diabetic Foot Ulcers","status":"WITHDRAWN","sponsor":"Integra LifeSciences Corporation","startDate":"2021-09","conditions":"Diabetic Foot Ulcer","enrollment":""},{"nctId":"NCT00630253","phase":"PHASE1, PHASE2","title":"Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2000-02-17","conditions":"Fanconi Anemia","enrollment":31},{"nctId":"NCT00629798","phase":"PHASE2","title":"Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2008-02-12","conditions":"Acute Myeloid Leukemia, Advanced Myelodysplastic Syndromes","enrollment":64},{"nctId":"NCT00919503","phase":"PHASE2","title":"Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2009-07-31","conditions":"Non-Neoplastic Hematologic and Lymphocytic Disorder","enrollment":98},{"nctId":"NCT03602898","phase":"PHASE2","title":"Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"WITHDRAWN","sponsor":"Fred Hutchinson Cancer Center","startDate":"2021-06-01","conditions":"Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia","enrollment":""},{"nctId":"NCT02424968","phase":"PHASE2","title":"CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma","status":"COMPLETED","sponsor":"Robert Lowsky","startDate":"2015-06","conditions":"Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia","enrollment":18},{"nctId":"NCT00813124","phase":"PHASE2","title":"Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2008-12","conditions":"Stem Cell Transplantation, Leukemia","enrollment":24},{"nctId":"NCT00943800","phase":"NA","title":"Combined Haploidentical-Cord Blood Transplantation for Adults and Children","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2006-10-09","conditions":"Leukemia, Myelodysplastic Syndrome, Multiple Myeloma","enrollment":87},{"nctId":"NCT00469014","phase":"PHASE2","title":"Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-09","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia","enrollment":72},{"nctId":"NCT00176930","phase":"NA","title":"Stem Cell Transplant for Hematological Malignancy","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2001-10","conditions":"Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute","enrollment":330},{"nctId":"NCT00506129","phase":"PHASE2","title":"Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2003-09","conditions":"Lymphoma, Disorder Related to Bone Marrow Transplantation","enrollment":33},{"nctId":"NCT00305682","phase":"PHASE2","title":"Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2005-06","conditions":"Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":295},{"nctId":"NCT00822770","phase":"PHASE1, PHASE2","title":"Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2009-01","conditions":"Stem Cell Transplantation, Leukemia","enrollment":47},{"nctId":"NCT00506948","phase":"PHASE2","title":"Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-09","conditions":"Hematological Malignancies, Myelodysplastic Syndrome, Leukemia","enrollment":13},{"nctId":"NCT02188719","phase":"PHASE1","title":"Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2014-12-17","conditions":"Liver Transplantation","enrollment":15},{"nctId":"NCT00068523","phase":"NA","title":"Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2003-06","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":10},{"nctId":"NCT00054236","phase":"PHASE1","title":"Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2002-05","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":55},{"nctId":"NCT03547635","phase":"NA","title":"AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Integra LifeSciences Corporation","startDate":"2018-05-03","conditions":"Diabetic Foot Ulcer","enrollment":116},{"nctId":"NCT03113786","phase":"PHASE4","title":"CLARIX™ 100 & CLARIX CORD 1K for Discectomy Patients","status":"COMPLETED","sponsor":"Amniox Medical, Inc.","startDate":"2011-11-02","conditions":"Protruded Disk","enrollment":32},{"nctId":"NCT00303719","phase":"PHASE2","title":"Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2002-03-26","conditions":"Kidney Cancer, Leukemia, Lymphoma","enrollment":342},{"nctId":"NCT01490723","phase":"PHASE2","title":"Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-01","conditions":"Leukemia, Lymphoma","enrollment":20},{"nctId":"NCT00566696","phase":"PHASE2","title":"Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2007-12-14","conditions":"Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML)","enrollment":73},{"nctId":"NCT02215200","phase":"PHASE2","title":"ATG-GCSF in New Onset Type 1 Diabetes","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2014-12","conditions":"Diabetes Mellitus, Type 1","enrollment":89},{"nctId":"NCT00787722","phase":"PHASE1, PHASE2","title":"Hematopoietic Stem Cell Transplant in Devic's Disease","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2009-10-10","conditions":"Devic's Disease","enrollment":13},{"nctId":"NCT00176852","phase":"PHASE2, PHASE3","title":"Stem Cell Transplant for Hemoglobinopathy","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2002-06","conditions":"Sickle Cell Disease, Thalassemia, Severe Congenital Neutropenia","enrollment":22},{"nctId":"NCT00053989","phase":"PHASE2","title":"NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2002-01-29","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":41},{"nctId":"NCT00899431","phase":"PHASE2","title":"Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2009-05-06","conditions":"Chronic Lymphocytic Leukemia","enrollment":39},{"nctId":"NCT00003270","phase":"PHASE2","title":"Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"1997-09-04","conditions":"Graft Versus Host Disease, Leukemia, Lymphoma","enrollment":20},{"nctId":"NCT00185692","phase":"PHASE2","title":"Allogeneic Transplantation From Related Haploidentical Donors","status":"COMPLETED","sponsor":"Stanford University","startDate":"2000-08","conditions":"Blood Cancer, Leukemia, Graft Versus Host Disease","enrollment":16},{"nctId":"NCT00046852","phase":"PHASE1, PHASE2","title":"Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2001-12","conditions":"Infection, Multiple Myeloma and Plasma Cell Neoplasm","enrollment":""},{"nctId":"NCT00003396","phase":"PHASE2","title":"Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"1998-09","conditions":"Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm","enrollment":42},{"nctId":"NCT00568633","phase":"PHASE3","title":"Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML","status":"TERMINATED","sponsor":"Stanford University","startDate":"2007-08","conditions":"Leukemia, Myeloid, Leukemia, Acute Myeloid Leukemia (AML)","enrollment":58},{"nctId":"NCT00550992","phase":"NA","title":"Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia","status":"UNKNOWN","sponsor":"Dutch Childhood Oncology Group","startDate":"2006-01","conditions":"Leukemia","enrollment":445},{"nctId":"NCT00434811","phase":"PHASE3","title":"Islet Transplantation in Type 1 Diabetes","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-10","conditions":"Type 1 Diabetes Mellitus","enrollment":48},{"nctId":"NCT01116232","phase":"PHASE2","title":"Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation","status":"TERMINATED","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"2010-08","conditions":"Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia","enrollment":4},{"nctId":"NCT02246491","phase":"NA","title":"Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia","status":"TERMINATED","sponsor":"Johns Hopkins University","startDate":"2015-02-03","conditions":"Ataxia-Telangiectasia (A-T)","enrollment":6},{"nctId":"NCT00709592","phase":"PHASE2","title":"Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2008-07-21","conditions":"Non-Hodgkin's Lymphoma, Leukemia, Multiple Myeloma","enrollment":42},{"nctId":"NCT02029638","phase":"PHASE2","title":"BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2014-01-07","conditions":"Kidney Transplantation","enrollment":4},{"nctId":"NCT03668145","phase":"NA","title":"Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis","status":"UNKNOWN","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2017-11-08","conditions":"Primary Biliary Cirrhosis","enrollment":140},{"nctId":"NCT03668171","phase":"NA","title":"Mesenchymal Stem Cell Transplantation for Acute-on-chronic Liver Failure","status":"UNKNOWN","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2017-12-10","conditions":"Acute-On-Chronic Liver Failure","enrollment":200},{"nctId":"NCT01598025","phase":"NA","title":"Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor","status":"TERMINATED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-05-02","conditions":"Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome","enrollment":3},{"nctId":"NCT00990249","phase":"PHASE2","title":"Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2009-10","conditions":"Leukemia, Lymphoma, Allogeneic Haematopoietic Stem Cell Transplantation","enrollment":120},{"nctId":"NCT00385788","phase":"PHASE2","title":"Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2005-07","conditions":"Hodgkin's Disease","enrollment":52},{"nctId":"NCT02322554","phase":"","title":"Cellular and Tissue Based Therapy Registry","status":"UNKNOWN","sponsor":"U.S. Wound Registry","startDate":"2005-01","conditions":"Diabetic Foot Ulcers, Venous Stasis Ulcer, Pressure Ulcer","enrollment":50000},{"nctId":"NCT00004474","phase":"PHASE3","title":"Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"1998-09","conditions":"Aplastic Anemia","enrollment":224},{"nctId":"NCT02225795","phase":"NA","title":"Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.","status":"WITHDRAWN","sponsor":"TriStar Health","startDate":"2014-08","conditions":"Crohn's Disease","enrollment":""},{"nctId":"NCT00617929","phase":"PHASE2","title":"Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2008-01","conditions":"Cancer","enrollment":12},{"nctId":"NCT00176904","phase":"PHASE2, PHASE3","title":"Stem Cell Transplant for Inborn Errors of Metabolism","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"1995-01","conditions":"Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy","enrollment":135},{"nctId":"NCT00392782","phase":"PHASE2","title":"Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2005-07","conditions":"Leukemia, Myelodysplastic Syndromes","enrollment":24},{"nctId":"NCT00176878","phase":"PHASE2, PHASE3","title":"Stem Cell Transplant for Bone Marrow Failure Syndromes","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2000-06","conditions":"Diamond-Blackfan Anemia, Kostmann's Neutropenia, Shwachman-Diamond Syndrome","enrollment":10},{"nctId":"NCT00176865","phase":"PHASE2","title":"Stem Cell Transplant for Immunologic or Histiocytic Disorders","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2002-08","conditions":"Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders, Chediak-Higashi Syndrome","enrollment":19}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":65,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Apligraf","Dermagraft","Epifix","Oasis","Talymed"],"phase":"phase_2","status":"active","brandName":"Cellular and tissue based products","genericName":"Cellular and tissue based products","companyName":"U.S. Wound Registry","companyId":"u-s-wound-registry","modality":"Biologic","firstApprovalDate":"","aiSummary":"This drug stimulates cellular and tissue repair. Used for Treatment of chronic wounds.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}